LENZ Therapeutics, Inc.
LENZ$363M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSOLANA BEACH
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Mar 31, 2026
7wData is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply
Market Overview
Stock performance and market intelligence
Catalyst Timeline
1 upcoming, 0 past
🎯PDUFANext
FDA PDUFA Date LENZ-123 (standard)
3/31/2026
For Alzheimer's disease. NDA filing. Extracted from SEC filing: 8-K
SourceAI Predictions & Institutional Flow
Machine learning insights and smart money movement
FDA Submissions
Pending NDA/BLA submissions with predicted PDUFA dates
Drug Pipeline
Clinical development programs and drug candidates
Drug Pipeline
No drugs found in this phase.
Regulatory & News
Approvals, filings, and latest developments
Regulatory Approvals
LENZ News